Agilent Technologies, Inc. (Santa Clara, California) Offers Grants for Research in Integrated Biology

SANTA CLARA Calif., July 14, 2011 – Agilent Technologies Inc. (NYSE: A) today announced that it is accepting entries for two systems biology research grants, both intended to spur development of open source data-integration tools. Each grant will provide $75,000 to a single academic or non-profit research lab in 2011.

Grant 1: Validating Protein Pathway Information – Integrating Proteomic Data with Transcriptomic or Metabolomic Datasets.

Grant 2: Modeling Disease Progression – Combining Gene Expression and Copy Number Variation Data.

The awards are open to principal investigators in foreign and domestic academic institutions and non-profit organizations. The submission deadline for these two grants is Aug. 12. Grant awards will be announced Sept. 30.

For more information or to apply, visit http://www.agilent.com/lifesciences/emerginginsights.

About Agilent Technologies

Agilent Technologies Inc. (NYSE: A) is the world’s premier measurement company and a technology leader in chemical analysis, life sciences, electronics and communications. The company’s 18,500 employees serve customers in more than 100 countries. Agilent had net revenues of $5.4 billion in fiscal 2010. Information about Agilent is available at www.agilent.com.

Further technology, corporate citizenship and executive news is available at www.agilent.com/go/news

Louise Muttram

Account Manager

dna medical communications

Fox Court, 14 Grays Inn Road

London, WC1X 8WS

United Kingdom

T:+44 (0)20 7067 0216

F:+44 (0)844 826 8317

LMuttram@dnamedcomms.com

MORE ON THIS TOPIC